Perioperative oxygenation—what's the stress?
Perioperative oxygenation—what's the stress?
Oxygen is the most used drug in anaesthesia. Despite such widespread use, optimal perioperative oxygen administration remains highly controversial because of concerns about the competing harms of both hyperoxia and hypoxia.
Notwithstanding a Cochrane review concluding that routinely administering a fractional inspired oxygen concentration (FiO2) >0.6 intraoperatively might increase postoperative morbidity and mortality, the World Health Organization (WHO) currently recommends all anaesthetised patients receive 0.8 FiO2 during and immediately after surgery to reduce surgical site infections. Results from the largest trial available at the time of these two reviews (suggesting long-term survival may be worse with high FiO2, particularly in patients with malignant disease) were considered ‘biologically implausible’ by the WHO's Guideline Development Group. In addition, the integrity of some perioperative oxygen studies has been challenged. Resolving these controversies is of fundamental importance to all perioperative clinicians.
This narrative review is based on the inaugural BJA William Mapleson lecture delivered by the senior author (AC) at the 2023 annual meeting of the Royal College of Anaesthetists in Birmingham. We present the current evidence for perioperative oxygen administration and contrast this with how oxygen therapy is targeted in other specialties (e.g. intensive care medicine). We will explore whether anaesthetists follow the WHO recommendations and consider how oxygen administration affects the stress response to surgery. We reason that novel clinical trial designs in combination with targeted experimental medicine studies will be required to improve our understanding of how best to optimise individualised perioperative oxygenation—a cornerstone of anaesthesia.
hyperoxia, hypoxia, oxidative stress, oxygen therapy, surgical site infections
Larvin, Joseph
84c19e04-3bbc-4946-8873-0ec50339d3e4
Edwards, Mark
818201d5-7636-4292-9af8-7dd8bcd1fcb5
Martin, Daniel S.
3e441b48-9221-4308-8ae6-49cbde20753f
Feelisch, Martin
8c1b9965-8614-4e85-b2c6-458a2e17eafd
Grocott, Michael P.W.
1e87b741-513e-4a22-be13-0f7bb344e8c2
Cumpstey, Andrew F.
cd040417-5e62-41d2-8640-1ec8905858a7
June 2024
Larvin, Joseph
84c19e04-3bbc-4946-8873-0ec50339d3e4
Edwards, Mark
818201d5-7636-4292-9af8-7dd8bcd1fcb5
Martin, Daniel S.
3e441b48-9221-4308-8ae6-49cbde20753f
Feelisch, Martin
8c1b9965-8614-4e85-b2c6-458a2e17eafd
Grocott, Michael P.W.
1e87b741-513e-4a22-be13-0f7bb344e8c2
Cumpstey, Andrew F.
cd040417-5e62-41d2-8640-1ec8905858a7
Larvin, Joseph, Edwards, Mark and Martin, Daniel S.
,
et al.
(2024)
Perioperative oxygenation—what's the stress?
BJA Open, 10, [100277].
(doi:10.1016/j.bjao.2024.100277).
Abstract
Oxygen is the most used drug in anaesthesia. Despite such widespread use, optimal perioperative oxygen administration remains highly controversial because of concerns about the competing harms of both hyperoxia and hypoxia.
Notwithstanding a Cochrane review concluding that routinely administering a fractional inspired oxygen concentration (FiO2) >0.6 intraoperatively might increase postoperative morbidity and mortality, the World Health Organization (WHO) currently recommends all anaesthetised patients receive 0.8 FiO2 during and immediately after surgery to reduce surgical site infections. Results from the largest trial available at the time of these two reviews (suggesting long-term survival may be worse with high FiO2, particularly in patients with malignant disease) were considered ‘biologically implausible’ by the WHO's Guideline Development Group. In addition, the integrity of some perioperative oxygen studies has been challenged. Resolving these controversies is of fundamental importance to all perioperative clinicians.
This narrative review is based on the inaugural BJA William Mapleson lecture delivered by the senior author (AC) at the 2023 annual meeting of the Royal College of Anaesthetists in Birmingham. We present the current evidence for perioperative oxygen administration and contrast this with how oxygen therapy is targeted in other specialties (e.g. intensive care medicine). We will explore whether anaesthetists follow the WHO recommendations and consider how oxygen administration affects the stress response to surgery. We reason that novel clinical trial designs in combination with targeted experimental medicine studies will be required to improve our understanding of how best to optimise individualised perioperative oxygenation—a cornerstone of anaesthesia.
Text
1-s2.0-S2772609624000212-main
- Version of Record
More information
Accepted/In Press date: 1 March 2024
e-pub ahead of print date: 20 March 2024
Published date: June 2024
Additional Information:
© 2024 The Authors.
Keywords:
hyperoxia, hypoxia, oxidative stress, oxygen therapy, surgical site infections
Identifiers
Local EPrints ID: 488640
URI: http://eprints.soton.ac.uk/id/eprint/488640
PURE UUID: 518f1ece-15e7-405b-95a8-e7f56ec7f1a8
Catalogue record
Date deposited: 27 Mar 2024 17:59
Last modified: 09 May 2024 02:02
Export record
Altmetrics
Contributors
Author:
Joseph Larvin
Author:
Mark Edwards
Author:
Daniel S. Martin
Author:
Andrew F. Cumpstey
Corporate Author: et al.
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics